MD Anderson and Broad Institute launch new translational research platform focused on rare cancers

(University of Texas M. D. Anderson Cancer Center) MD Anderson and the Broad Institute have launched a translational research platform to study rare cancers. The initiative will lead to a first-of-its-kind resource for the scientific community and will help to accelerate new therapies for patients with rare tumor types.